Figure 3.
Figure 3. Effect of CY on apoptosis in CD4+25+TREGs and CD4+25- cells. (A-B) TUNEL staining of CD4+25+ cells. Two days after the intraperitoneal administration of 2 mg CY, spleen cells were removed, and CD4+25+ cells were separated by magnetic bead separation and fluorescence-activated cell sorting (FACS). CD4+25+ cells from treated or control mice were incubated with bound anti-CD3, and TUNEL staining was performed after 24 hours in culture. (A) CD4+25+ cells from untreated control mice. (B) CD4+25+ cells from CY-treated mice. Data are representative of 2 separate experiments. (C-D) TUNEL staining of CD4+25- cells. Two days after the intraperitoneal administration of 2 mg CY, spleen cells were removed, and CD4+25- cells were separated by magnetic bead separation and FACS. CD4+25- cells from treated or control mice were incubated with bound anti-CD3 and after 24 hours in culture, TUNEL staining was performed. (C) CD4+25- cells from untreated control mice. (D) CD4+25- cells from CY-treated mice. Data are representative of 2 separate experiments. Percentages in panels A-D indicate the percent of apoptotic cells. (E-F) Annexin V staining of CD4+25+ cells. Two days after the intraperitoneal administration of 2 mg CY, spleen and LN cells were removed. Freshly isolated cells were stained for cell surface markers, and Annexin V staining was performed on the samples. (E) Annexin V profile of CD4+25+ LN cells from CY-treated mice (black solid histogram) compared with CD4+25+ LN cells from control mice (gray line histogram). (F) Annexin V profile of CD4+25+ spleen cells from CY-treated mice (black solid histogram) compared with CD4+25+ spleen cells from control mice (gray line histogram). (G-H) Annexin V staining of CD4+25- cells. Two days after the intraperitoneal administration of 2 mg CY, spleen and LN cells were removed. Freshly isolated cells were stained for cell surface markers, and Annexin V staining was performed on the samples. (G) Annexin V profile of CD4+25- LN cells from CY-treated mice (black solid histogram) compared with CD4+25- LN cells from control mice (gray line histogram). (H) Annexin V profile of CD4+25- spleen cells from CY-treated mice (black solid histogram) compared with CD4+25- spleen cells from control mice (gray line histogram). Horizontal bars in panels E and H are gates indicating what percent of cells are positive for apoptotic cells.

Effect of CY on apoptosis in CD4+25+TREGs and CD4+25- cells. (A-B) TUNEL staining of CD4+25+ cells. Two days after the intraperitoneal administration of 2 mg CY, spleen cells were removed, and CD4+25+ cells were separated by magnetic bead separation and fluorescence-activated cell sorting (FACS). CD4+25+ cells from treated or control mice were incubated with bound anti-CD3, and TUNEL staining was performed after 24 hours in culture. (A) CD4+25+ cells from untreated control mice. (B) CD4+25+ cells from CY-treated mice. Data are representative of 2 separate experiments. (C-D) TUNEL staining of CD4+25- cells. Two days after the intraperitoneal administration of 2 mg CY, spleen cells were removed, and CD4+25- cells were separated by magnetic bead separation and FACS. CD4+25- cells from treated or control mice were incubated with bound anti-CD3 and after 24 hours in culture, TUNEL staining was performed. (C) CD4+25- cells from untreated control mice. (D) CD4+25- cells from CY-treated mice. Data are representative of 2 separate experiments. Percentages in panels A-D indicate the percent of apoptotic cells. (E-F) Annexin V staining of CD4+25+ cells. Two days after the intraperitoneal administration of 2 mg CY, spleen and LN cells were removed. Freshly isolated cells were stained for cell surface markers, and Annexin V staining was performed on the samples. (E) Annexin V profile of CD4+25+ LN cells from CY-treated mice (black solid histogram) compared with CD4+25+ LN cells from control mice (gray line histogram). (F) Annexin V profile of CD4+25+ spleen cells from CY-treated mice (black solid histogram) compared with CD4+25+ spleen cells from control mice (gray line histogram). (G-H) Annexin V staining of CD4+25- cells. Two days after the intraperitoneal administration of 2 mg CY, spleen and LN cells were removed. Freshly isolated cells were stained for cell surface markers, and Annexin V staining was performed on the samples. (G) Annexin V profile of CD4+25- LN cells from CY-treated mice (black solid histogram) compared with CD4+25- LN cells from control mice (gray line histogram). (H) Annexin V profile of CD4+25- spleen cells from CY-treated mice (black solid histogram) compared with CD4+25- spleen cells from control mice (gray line histogram). Horizontal bars in panels E and H are gates indicating what percent of cells are positive for apoptotic cells.

Close Modal

or Create an Account

Close Modal
Close Modal